Literature DB >> 31402157

The association between pulmonary hypertension and stroke: A systematic review and meta-analysis.

Trushil G Shah1, Jaini M Sutaria2, Manav V Vyas3.   

Abstract

BACKGROUND: Pulmonary hypertension is associated with atrial fibrillation and paradoxical embolism. Yet, the association between pulmonary hypertension and stroke has not been well studied.
METHODS: We reviewed Medline and Embase from inception to December 1, 2018, to identify observational studies reporting prevalence of stroke in adult patients with pulmonary hypertension. We sought studies that included patients with pulmonary hypertension secondary to any etiology except left heart failure, and excluded studies that reported rates of perioperative stroke. We conducted random effects meta-analyses to obtain pooled prevalence of stroke in patients with pulmonary hypertension, and pooled unadjusted odds ratio of stroke in patients with pulmonary hypertension compared to those without.
RESULTS: We included 14 studies including 32,523 participants of which 2976 (9.2%) had pulmonary hypertension, and 727 (2.2%) had a stroke. The pooled prevalence of stroke in patients with pulmonary hypertension was 8.0% [95% confidence interval (CI), 5.1%-10.9%, I2 91.9]. The pooled unadjusted odds ratio of stroke in patients with pulmonary hypertension compared to those without was 1.46 (95% CI, 1.07-1.99, I2 55.6, n = 7 studies).
CONCLUSION: Stroke is a major non-cardiac morbidity in patients with pulmonary hypertension, requiring further evaluation to determine its etiology, and measures to reduce its risk.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Meta-analysis; Observational studies; Pulmonary hypertension; Stroke; Systematic review

Mesh:

Year:  2019        PMID: 31402157     DOI: 10.1016/j.ijcard.2019.07.085

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1. 

Authors:  José María Barrios-López; Iago Rego-García; María Dolores Fernández Pérez
Journal:  Neurologia (Engl Ed)       Date:  2021-04-09

2.  Reply.

Authors:  José María Trejo-Gabriel-Galán
Journal:  Neurologia       Date:  2021-04-09       Impact factor: 3.109

3.  Sex Differences in Ischemic Stroke Outcomes in Patients With Pulmonary Hypertension.

Authors:  Tiberiu A Pana; Dana K Dawson; Mohamed O Mohamed; Fiona Murray; David L Fischman; Michael P Savage; Mamas A Mamas; Phyo K Myint
Journal:  J Am Heart Assoc       Date:  2021-03-08       Impact factor: 5.501

4.  Reply.

Authors:  José María Trejo-Gabriel-Galán
Journal:  Neurologia (Engl Ed)       Date:  2021-09

5.  Clinical impact of right ventricular-pulmonary artery uncoupling on predicting the clinical outcomes after catheter ablation in persistent atrial fibrillation patients.

Authors:  Masamichi Yano; Yasuyuki Egami; Kohei Ukita; Akito Kawamura; Hitoshi Nakamura; Yutaka Matsuhiro; Koji Yasumoto; Masaki Tsuda; Naotaka Okamoto; Yasuharu Matsunaga-Lee; Masami Nishino; Jun Tanouchi
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-05

Review 6.  Human gut microbiota in health and disease: Unveiling the relationship.

Authors:  Muhammad Afzaal; Farhan Saeed; Yasir Abbas Shah; Muzzamal Hussain; Roshina Rabail; Claudia Terezia Socol; Abdo Hassoun; Mirian Pateiro; José M Lorenzo; Alexandru Vasile Rusu; Rana Muhammad Aadil
Journal:  Front Microbiol       Date:  2022-09-26       Impact factor: 6.064

7.  Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Zhengyang Lu; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

8.  Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension.

Authors:  Simon Malenfant; Patrice Brassard; Myriam Paquette; Olivier Le Blanc; Audrey Chouinard; Sébastien Bonnet; Steeve Provencher
Journal:  Physiol Rep       Date:  2020-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.